In the field of cardiovascular risk reduction and Lipidology, Dr. Scott Grundy is one of the best renowned experts in the world. Dr. Grundy is past chair of the 2001 National Cholesterol Education Program Adult Treatment Panel III guidelines, recipient of numerous awards including the Distinguished Achievement Award in 2010 by the National Lipid Association, and lead author on the current Global Recommendations for the Management of Dyslipidemia published by the International Atherosclerosis Society. Dr. Grundy’s bold critique of the 2013 ACC/AHA Cholesterol guideline is found in the August issue of the Journal of the American College of Cardiology. After his well referenced review, he concludes by stating that the 2013 ACC/AHA Cholesterol Guideline provides a “public health strategy” rather than “a clinical strategy” and that it is indeed “unfortunate” that we have this cholesterol guideline with shortcomings due to the “panel’s misapplication of the so-called evidence-based approach.” He concludes by sharing his concern that “virtually no guidance is provided to the caregiver for how to adjust the guidelines to best fit the patient.”
Reference: Smith SC and Grundy SM. 2013 ACC/AHA guideline recommends fixed-dose strategies instead of targeted goals to lower blood cholesterol. J Am Coll Cardiol 2014;64:601-612.